Table 1.
3D-CRT | IMRT | P-value | |
---|---|---|---|
(n = 55) | (n = 74) | ||
Age (mean) | 55–79 (69.3) | 49–84 (70.0) | 0.589 |
NCCN risk group | |||
Low | 4 | 9 | |
Intermediate | 20 | 31 | |
High | 24 | 27 | |
Very high | 7 | 7 | 0.904 |
T1c | 24 | 55 | 0.023 |
T2a | 10 | 6 | |
T2b | 6 | 2 | |
T2c | 1 | 0 | |
T3a | 7 | 4 | |
T3b | 7 | 7 | |
Gleason score | |||
5–6 | 9 | 16 | |
7 | 35 | 29 | |
8–10 | 11 | 29 | 0.006 |
PSA (ng/ml) | |||
<10 | 17 | 35 | |
10–20 | 16 | 26 | |
>20 | 22 | 13 | 0.180 |
Hypertension | 24 | 27 | 0.213 |
Diabetes mellitus | 7 | 7 | 0.553 |
Usage of anticoagulants | 6 | 17 | 0.154 |